Shanghao Liu

机构：Zhongda Hospital Southeast University · ORCID：0009-0008-3943-2931

发表论文 35 篇 · 总被引 254 次 · h-index 9

代表论文

• Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Population‐Based Cohort Study (2025 · Alimentary Pharmacology & Therapeutics · 被引 22)
• Post‐ TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study (2025 · Alimentary Pharmacology & Therapeutics · 被引 18)
• LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population (2024 · Med · 被引 17)
• Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) (2025 · Communications Medicine · 被引 14)
• High prevalence of steatotic liver disease and fibrosis in the general population: A large prospective study in China (2024 · Journal of Hepatology · 被引 14)
• Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study (2025 · Clinical and Molecular Hepatology · 被引 8)